Market Insights: Geron Corp. (GERN)’s Notable Gain of 3.90, Closing at 4.53

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Geron Corp.’s stock clocked out at $4.53, up 3.90% from its previous closing price of $4.36. In other words, the price has increased by $3.90 from its previous closing price. On the day, 5.49 million shares were traded. GERN stock price reached its highest trading level at $4.545 during the session, while it also had its lowest trading level at $4.32.

Ratios:

To gain a deeper understanding of GERN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.67 and its Current Ratio is at 3.67. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.04.

On April 29, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $10.

Needham reiterated its Buy rating for the stock on March 15, 2024, while the target price for the stock was revised from $4 to $5.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 10 ’24 when Kapur Anil sold 421,875 shares for $4.64 per share. The transaction valued at 1,959,609 led to the insider holds 0 shares of the business.

Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 04 ’24, another insider, SCARLETT JOHN A, who serves as the Chairman, President and CEO of the company, sold 600,000 shares for $4.00 each. As a result, the insider received 2,400,000 and left with 600,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 2686892544 and an Enterprise Value of 2330370304. For the stock, the TTM Price-to-Sale (P/S) ratio is 5167.08 while its Price-to-Book (P/B) ratio in mrq is 7.77. Its current Enterprise Value per Revenue stands at 4481.482 whereas that against EBITDA is -11.122.

Stock Price History:

The Beta on a monthly basis for GERN is 0.48, which has changed by 0.41562498 over the last 52 weeks, in comparison to a change of 0.26253593 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is 11.59%, while the 200-Day Moving Average is calculated to be 68.04%.

Shares Statistics:

It appears that GERN traded 11.90M shares on average per day over the past three months and 10007630 shares per day over the past ten days. A total of 544.91M shares are outstanding, with a floating share count of 500.46M. Insiders hold about 15.62% of the company’s shares, while institutions hold 58.22% stake in the company. Shares short for GERN as of 1718323200 were 54116763 with a Short Ratio of 4.55, compared to 1715731200 on 53888364. Therefore, it implies a Short% of Shares Outstanding of 54116763 and a Short% of Float of 9.1800004.

Earnings Estimates

The current rating of Geron Corp. (GERN) is the result of assessments by 8.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.11, while EPS last year was -$0.09. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.12.

Analysts are recommending an EPS of between -$0.31 and -$0.42 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.19, with 7.0 analysts recommending between -$0.02 and -$0.27.

Revenue Estimates

For the next quarter, 8 analysts are estimating revenue of $15.92M. There is a high estimate of $22.5M for the next quarter, whereas the lowest estimate is $5.2M.

A total of 8 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $73.29M, while the lowest revenue estimate was $24.8M, resulting in an average revenue estimate of $52.02M. In the same quarter a year ago, actual revenue was $237kBased on 8 analysts’ estimates, the company’s revenue will be $253.29M in the next fiscal year. The high estimate is $360.44M and the low estimate is $179.24M.

Most Popular